Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 10, 2010, Pages 1113-1119

  Chopra, Teena ^a   Alangaden, George J ^a   Chandrasekar, Pranatharthi ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chemotherapy; Clostridium difficile; epidemiology; hematopoietic stem cell transplant

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLUTAMATE DEHYDROGENASE; IRINOTECAN; METHOTREXATE; METRONIDAZOLE; NAVELBINE; PACLITAXEL; TOPOTECAN; VANCOMYCIN; VINBLASTINE;

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL TENDERNESS; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHORIOCARCINOMA; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON CANCER; COLORECTAL CANCER; DIARRHEA; DRUG FATALITY; ENTEROCOLITIS; ENZYME IMMUNOASSAY; FECES CULTURE; GERM CELL TUMOR; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GYNECOLOGIC CANCER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION RISK; LENGTH OF STAY; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NONHODGKIN LYMPHOMA; OVARY CANCER; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; TESTIS CANCER; TISSUE CULTURE TECHNIQUE;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; SEVERITY OF ILLNESS INDEX;

EID: 77958175876     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.10.95     Document Type: Review

References (63)

1. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium diffcile. N. Engl. J. Med. 353(23), 2433-2441 (2005).
2. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibioticassociated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298(10), 531-534 (1978).
3. McDonald LC, Owings M, Jernigan DB. Clostridium diffcile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg. Infect. Dis. 12(3), 409-415 (2006).
4. Blossom DB, McDonald LC. The challenges posed by reemerging Clostridium diffcile infection. Clin. Infect. Dis. 45(2), 222-227 (2007).
5. Owens RC. Clostridium diffcileassociated disease: changing epidemiology and implications for management. Drugs 67(4), 487-502 (2007).
6. Kelly CP, LaMont JT. Clostridium diffcile-more diffcult than ever. N. Engl. J. Med. 359(18), 1932-1940 (2008).
7. Bartlett JG. Clinical practice. Antibioticassociated diarrhea. N. Engl. J. Med. 346(5), 334-339 (2002).
8. Kelly CP, Pothoulakis C, LaMont JT. Clostridium diffcile colitis. N. Engl. J. Med. 330(4), 257-262 (1994).
9. Chopra T, Chandrasekar PH, Salimnia H, Merline J, Alangaden GJ. Current epidemiology of Clostridium diffcile associated disease (CDAD) in hematopoietic stem cell transplant recipients (HSCT). Presented at: 45th Annual Meeting Infectious Diseases Society of America (IDSA). San Diego, CA, USA, 4-7 October 2007.
10. Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium diffcileassociated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant. 42(11), 705-713 (2008). •• Most recent comprehensive review of Clostridium diffcile infection (CDI) in stem cell transplant recipients.
11. Bilgrami S, Feingold JM, Dorsky D et al. Incidence and outcome of Clostridium diffcile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 23(10), 1039-1042 (1999).
12. Rampling A, Warren RE, Bevan PC et al. Clostridium diffcile in haematological malignancy. J. Clin. Pathol. 38(4), 445-451 (1985).
13. Heard SR, Wren B, Barnett MJ, Thomas JM, Tabaqchali S. Clostridium diffcile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains. Epidemiol. Infect. 100(1), 63-72 (1988).
14. Raza S, Baig MA, Russell H, Gourdet Y, Berger BJ. Clostridium diffcile infection following chemotherapy. Recent Pat. Antiinfect. Drug Discov. 5(1), 1-9 (2010). • Descriptive review on the pathogenesis of CDI associated with different chemotherapeutic agents.
15. Hornbuckle K, Chak A, Lazarus HM et al. Determination and validation of a predictive model for Clostridium diffcile diarrhea in hospitalized oncology patients. Ann. Oncol. 9(3), 307-311 (1998).
16. Dubberke ER, Reske KA, Srivastava A et al. Clostridium diffcile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin. Transplant. 24(2), 192-198 (2009). • Recent large case-control study of CDI in allogeneic stem cell transplant recipients.
17. Dubberke ER, Riddle DJ. Clostridium diffcile in solid organ transplant recipients. Am. J. Transplant. 9 (Suppl. 4), S35-S40 (2009).
18. Anand A, Glatt AE. Clostridium diffcile infection associated with antineoplastic chemotherapy: a review. Clin. Infect. Dis. 17(1), 109-113 (1993).
19. Kontoyiannis DP, Lewis RE, Marr K. The burden of bacterial and viral infections in hematopoietic stem cell transplant. Biol. Blood Marrow Transplant. 15 (1 Suppl.), 128-133 (2009).
20. Husain A, Aptaker L, Spriggs DR, Barakat RR. Gastrointestinal toxicity and Clostridium diffcile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecol. Oncol. 71(1), 104-107 (1998).
21. Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K. Clostridium diffcile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol. Oncol. 61(3), 369-372 (1996).
22. Gorschluter M, Glasmacher A, Hahn C et al. Clostridium diffcile infection in patients with neutropenia. Clin. Infect. Dis. 33(6), 786-791 (2001).
23. Fainstein V, Bodey GP, Fekety R. Relapsing pseudomembranous colitis associated with cancer chemotherapy. J. Infect. Dis. 143(6), 865 (1981).
24. Silva J, Fekety R, Werk C et al. Inciting and etiologic agents of colitis. Rev. Infect. Dis. 6 (Suppl. 1), S214-S221 (1984).
25. Yamazawa K, Kanno H, Seki K et al. Life-threatening Clostridium diffcileassociated diarrhea induced by paclitaxelcarboplatin combination chemotherapy. Acta Obstet. Gynecol. Scand. 80(8), 768-769 (2001).
26. Ansari J, Choo B, Fernando I. Fatal Clostridium diffcile infection associated with vinorelbine chemotherapy: case report and literature review. J. Infect. Chemother. 16(3), 210-212 (2010).
27. Maeda Y, Yamazaki K, Kikuchi E et al. [A case of Clostridium diffcile colitis associated with paclitaxel and carboplatin chemotherapy for lung cancer]. Nihon Kokyuki Gakkai Zasshi 43(11), 668-672 (2005).
28. Taylor SG, Hass GM, Crumrine JL, Slaughter DP. Toxic reactions of 4-amino-pteroylglutamic acid (aminopterin) in patients with far-advanced neoplastic disease. Cancer 3(3), 493-503 (1950).
29. Boukhettala N, Leblond J, Claeyssens S et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am. J. Physiol. Endocrinol. Metab. 296(1), E182-E190 (2009).
30. Stringer AM, Gibson RJ, Logan RM et al. Faecal microfora and β-glucuronidase expression are altered in an irinotecaninduced diarrhea model in rats. Cancer Biol. Ther. 7(12), 1919-1925 (2008).
31. Larson HE, Price AB, Borriello SP. Epidemiology of experimental enterocecitis due to Clostridium diffcile. J. Infect. Dis. 142(3), 408-413 (1980).
32. Toshniwal R, Silva J Jr, Fekety R, Kim KH. Studies on the epidemiology of colitis due to Clostridium diffcile in hamsters. J. Infect. Dis. 143(1), 51-54 (1981).
33. Johnson S, Clabots CR, Linn FV et al. Nosocomial Clostridium diffcile colonisation and disease. Lancet 336(8707), 97-100 (1990).
34. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium diffcile-associated diarrhea with high morbidity and mortality N. Engl. J. Med. 353(23), 2442-2449 (2005).
35. Rojas S, Cohen SH, Tang YJ et al. Differing epidemiology of Clostridium diffcile-associated diarrhea between an oncology ward and a general medicine ward. Infect. Control Hosp. Epidemiol. 20(1), 14-15 (1999).
36. Cohen SH, Tang YJ, Muenzer J, Gumerlock PH, Silva J Jr. Isolation of various genotypes of Clostridium diffcile from patients and the environment in an oncology ward. Clin. Infect. Dis. 24(5), 889-893 (1997).
37. Chopra T, Bernabela L, MacNamara S et al. Molecular and epidemiological characterization of Clostridium diffcile strains in a tertiary care hospital. Presented at: 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Fransisco, CA, USA, 12-15 September 2009 (Abstract K 2080).
38. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium diffcile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31(5), 431-455 (2010). •• Recent US Infectious Diseases Society of America guidelines on the diagnosis and management of CDI.
39. Mossad SB, Longworth DL, Goormastic M et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant. 18(2), 265-271 (1996).
40. Avery R, Pohlman B, Adal K et al. High prevalence of diarrhea but infrequency of documented Clostridium diffcile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant. 25(1), 67-69 (2000).
41. van Kraaij MG, Dekker AW, Verdonck LF et al. Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant. 26(3), 299-303 (2000).
42. Barton T, Collis T, Stadtmauer E, Schuster M. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer. Clin. Infect. Dis. 32(3), 391-395 (2001).
43. Yuen KY, Woo PC, Liang RH et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients. Diagn. Microbiol. Infect. Dis. 30(2), 75-81 (1998).
44. Arango JI, Restrepo A, Schneider DL et al. Incidence of Clostridium diffcile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant. 37(5), 517-521 (2006).
45. Dettenkofer M, Ebner W, Bertz H et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant. 31(9), 795-801 (2003).
46. Jank T, Giesemann T, Aktories K. Rho-glucosylating Clostridium diffcile toxins A and B: new insights into structure and function. Glycobiology 17(4), R15-R22 (2007).
47. Bobak DA. The molecular pathogenesis of Clostridium diffcile-associated disease. Curr. Infect. Dis. Rep. 10(2), 111-115 (2008).
48. Kyne L, Farrell RJ, Kelly CP. Clostridium diffcile. Gastroenterol. Clin. North Am. 30(3), 753-777; IX-X (2001).
49. Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium diffcile infection in allogeneic stem cell transplant recipients is associated with severe graft-vers us-host disease and non-relapse mortality. Bone Marrow Transplant. 26(8), 871-876 (2000).
50. Peterson LR, Robicsek A. Does my patient have Clostridium diffcile infection? Ann. Intern. Med. 151(3), 176-179 (2009).
51. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium diffcile-infection (CDI). Clin. Microbiol. Infect. 15(12), 1053-1066 (2009). •• Recent European Society of Clinical Microbiology and Infectious Diseases guidelines on the diagnosis of CDI.
52. Peterson LR, Manson RU, Paule SM et al. Detection of toxigenic Clostridium diffcile in stool samples by real-time polymerase chain reaction for the diagnosis of C diffcile-associated diarrhea. Clin. Infect. Dis. 45(9), 1152-1160 (2007). • Shows the utility of PCR in the diagnosis of CDI.
53. Eastwood K, Else P, Charlett A, Wilcox M. Comparison of nine commercially available Clostridium diffcile toxin detection assays, a real-time PCR assay for C diffcile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47(10), 3211-3217 (2009).
54. Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium diffcile infection (CDI). Clin. Microbiol. Infect. 15(12), 1067-1079 (2009). •• Recent European Society of Clinical Microbiology and Infectious Diseases guidelines on the treatment of CDI.
55. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium diffcile-associated diarrhea, stratifed by disease severity. Clin. Infect. Dis. 45(3), 302-307 (2007). • Documented superiority of vancomycin over metronidazole in the treatment of severe CDI.
56. Nielsen H, Daugaard G, Tvede M, Bruun B. High prevalence of Clostridium diffcile diarrhoea during intensive chemotherapy for disseminated germ cell cancer. Br. J. Cancer 66(4), 666-667 (1992).
57. Paterson DL. Clostridium diffcile diarrhoea associated with chemotherapy for ovarian cancer. Aust. NZJ Obstet. Gynaecol. 37(3), 348-349 (1997).
58. Wong AS, Lam CS, Tambyah PA. Fatal chemotherapy associated Clostridium diffcile infection-a case report. Singapore Med. J. 42(5), 214-216 (2001).
59. Morales Chamorro R, Serrano Blanch R, Mendez Vidal MJ et al. Pseudomembranous colitis associated with chemotherapy with 5-fuorouracil. Clin. Transl. Oncol. 7(6), 258-261 (2005).
60. Yang SW, Moon W. [A case of pseudomenbranous colitis after paclitaxel and carboplatin chemotherapy]. Korean J. Gastroenterol. 54(5), 328-332 (2009).
61. Cox GJ, Matsui SM, Lo RS et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 107(5), 1398-1407 (1994).
62. Tomblyn M, Gordon L, Singhal S et al. Rarity of toxigenic Clostridium diffcile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone Marrow Transplant. 30(8), 517-519 (2002).
63. Jillella AP, Ustun C, Robach E et al. Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection. J. Hematother. Stem Cell Res. 12(2), 155-160 (2003).